Details for Patent: 7,538,125
Summary for Patent: 7,538,125
| Title: | Pharmaceutical composition |
| Abstract: | Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes. |
| Inventor(s): | Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka |
| Assignee: | Takeda Pharmaceutical Co Ltd |
| Application Number: | US11/523,771 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 7,538,125
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,538,125
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 1995-153500 | Jun 20, 1995 |
International Family Members for US Patent 7,538,125
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0861666 | ⤷ Start Trial | 91298 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 0861666 | ⤷ Start Trial | 300258 | Netherlands | ⤷ Start Trial |
| European Patent Office | 0861666 | ⤷ Start Trial | SPC 038/2006 | Ireland | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
